US Stock MarketDetailed Quotes

Arcus Biosciences (RCUS)

Watchlist
  • 25.500
  • +0.370+1.47%
Close Apr 24 16:00 ET
  • 25.750
  • +0.250+0.98%
Post 17:03 ET
3.20BMarket Cap-7.75P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Arcus Biosciences (RCUS) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
-4.26%247M
26.92%33M
-45.83%26M
310.26%160M
-80.69%28M
120.51%258M
-16.13%26M
50.00%48M
34.48%39M
480.00%145M
Operating revenue
-4.26%247M
26.92%33M
-45.83%26M
310.26%160M
-80.69%28M
120.51%258M
-16.13%26M
50.00%48M
34.48%39M
480.00%145M
Cost of revenue
Gross profit
Operating expense
11.44%633M
13.95%147M
9.80%168M
15.86%168M
6.38%150M
24.29%568M
5.74%129M
36.61%153M
29.46%145M
27.03%141M
Selling and administrative expenses
-8.33%110M
-7.14%26M
-10.00%27M
-3.33%29M
-12.50%28M
2.56%120M
-3.45%28M
0.00%30M
7.14%30M
6.67%32M
-General and administrative expense
-8.33%110M
-7.14%26M
-10.00%27M
-3.33%29M
-12.50%28M
2.56%120M
-3.45%28M
0.00%30M
7.14%30M
6.67%32M
Research and development costs
16.74%523M
19.80%121M
14.63%141M
20.87%139M
11.93%122M
31.76%448M
8.60%101M
50.00%123M
36.90%115M
34.57%109M
Operating profit
-24.52%-386M
-10.68%-114M
-35.24%-142M
92.45%-8M
-3,150.00%-122M
8.82%-310M
-13.19%-103M
-31.25%-105M
-27.71%-106M
104.65%4M
Net non-operating interest income expense
-31.25%33M
-20.00%8M
-46.15%7M
-38.46%8M
-16.67%10M
23.08%48M
-9.09%10M
18.18%13M
44.44%13M
50.00%12M
Non-operating interest income
-21.15%41M
-16.67%10M
-28.57%10M
-23.08%10M
-15.38%11M
26.83%52M
9.09%12M
16.67%14M
44.44%13M
44.44%13M
Non-operating interest expense
100.00%8M
0.00%2M
200.00%3M
--2M
0.00%1M
100.00%4M
--2M
0.00%1M
--0
0.00%1M
Other net income (expense)
-20M
0
-20M
Special income (charges)
--0
--0
--0
--0
--0
---20M
--0
--0
--0
---20M
-Less:Impairment of capital assets
--0
--0
--0
--0
--0
--20M
--0
--0
--0
--20M
Income before tax
-25.18%-353M
-13.98%-106M
-46.74%-135M
0
-2,700.00%-112M
6.31%-282M
-16.25%-93M
-33.33%-92M
-25.68%-93M
94.87%-4M
Income tax
0
0
0
0
0
-83.33%1M
0.00%1M
0
0
0
Net income
-24.73%-353M
-12.77%-106M
-46.74%-135M
0
-2,700.00%-112M
7.82%-283M
-16.05%-94M
-29.58%-92M
-24.00%-93M
95.00%-4M
Net income continuous Operations
-24.73%-353M
-12.77%-106M
-46.74%-135M
--0
-2,700.00%-112M
7.82%-283M
-16.05%-94M
-29.58%-92M
-24.00%-93M
95.00%-4M
Minority interest income
Net income attributable to the parent company
-24.73%-353M
-12.77%-106M
-46.74%-135M
0
-2,700.00%-112M
7.82%-283M
-16.05%-94M
-29.58%-92M
-24.00%-93M
95.00%-4M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-24.73%-353M
-12.77%-106M
-46.74%-135M
0
-2,700.00%-112M
7.82%-283M
-16.05%-94M
-29.58%-92M
-24.00%-93M
95.00%-4M
Basic earnings per share
-4.78%-3.29
13.59%-0.89
-27.00%-1.27
0
-2,180.00%-1.14
24.34%-3.14
4.63%-1.03
-6.38%-1
1.92%-1.02
95.41%-0.05
Diluted earnings per share
-4.78%-3.29
13.59%-0.89
-27.00%-1.27
0
-2,180.00%-1.14
24.34%-3.14
4.63%-1.03
-6.38%-1
1.92%-1.02
95.41%-0.05
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue -4.26%247M26.92%33M-45.83%26M310.26%160M-80.69%28M120.51%258M-16.13%26M50.00%48M34.48%39M480.00%145M
Operating revenue -4.26%247M26.92%33M-45.83%26M310.26%160M-80.69%28M120.51%258M-16.13%26M50.00%48M34.48%39M480.00%145M
Cost of revenue
Gross profit
Operating expense 11.44%633M13.95%147M9.80%168M15.86%168M6.38%150M24.29%568M5.74%129M36.61%153M29.46%145M27.03%141M
Selling and administrative expenses -8.33%110M-7.14%26M-10.00%27M-3.33%29M-12.50%28M2.56%120M-3.45%28M0.00%30M7.14%30M6.67%32M
-General and administrative expense -8.33%110M-7.14%26M-10.00%27M-3.33%29M-12.50%28M2.56%120M-3.45%28M0.00%30M7.14%30M6.67%32M
Research and development costs 16.74%523M19.80%121M14.63%141M20.87%139M11.93%122M31.76%448M8.60%101M50.00%123M36.90%115M34.57%109M
Operating profit -24.52%-386M-10.68%-114M-35.24%-142M92.45%-8M-3,150.00%-122M8.82%-310M-13.19%-103M-31.25%-105M-27.71%-106M104.65%4M
Net non-operating interest income expense -31.25%33M-20.00%8M-46.15%7M-38.46%8M-16.67%10M23.08%48M-9.09%10M18.18%13M44.44%13M50.00%12M
Non-operating interest income -21.15%41M-16.67%10M-28.57%10M-23.08%10M-15.38%11M26.83%52M9.09%12M16.67%14M44.44%13M44.44%13M
Non-operating interest expense 100.00%8M0.00%2M200.00%3M--2M0.00%1M100.00%4M--2M0.00%1M--00.00%1M
Other net income (expense) -20M0-20M
Special income (charges) --0--0--0--0--0---20M--0--0--0---20M
-Less:Impairment of capital assets --0--0--0--0--0--20M--0--0--0--20M
Income before tax -25.18%-353M-13.98%-106M-46.74%-135M0-2,700.00%-112M6.31%-282M-16.25%-93M-33.33%-92M-25.68%-93M94.87%-4M
Income tax 00000-83.33%1M0.00%1M000
Net income -24.73%-353M-12.77%-106M-46.74%-135M0-2,700.00%-112M7.82%-283M-16.05%-94M-29.58%-92M-24.00%-93M95.00%-4M
Net income continuous Operations -24.73%-353M-12.77%-106M-46.74%-135M--0-2,700.00%-112M7.82%-283M-16.05%-94M-29.58%-92M-24.00%-93M95.00%-4M
Minority interest income
Net income attributable to the parent company -24.73%-353M-12.77%-106M-46.74%-135M0-2,700.00%-112M7.82%-283M-16.05%-94M-29.58%-92M-24.00%-93M95.00%-4M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -24.73%-353M-12.77%-106M-46.74%-135M0-2,700.00%-112M7.82%-283M-16.05%-94M-29.58%-92M-24.00%-93M95.00%-4M
Basic earnings per share -4.78%-3.2913.59%-0.89-27.00%-1.270-2,180.00%-1.1424.34%-3.144.63%-1.03-6.38%-11.92%-1.0295.41%-0.05
Diluted earnings per share -4.78%-3.2913.59%-0.89-27.00%-1.270-2,180.00%-1.1424.34%-3.144.63%-1.03-6.38%-11.92%-1.0295.41%-0.05
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +16.17%
Sample Name
Sample Code
 +12.91%
Sample Name
Sample Code
 +12.09%
4
VanEck Oil Services ETF
OIH
+5.81%
5
ProShares Ultra Bloomberg Crude Oil ETF
UCO
+4.91%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +12.90%
Sample Name
Sample Code
 +11.93%
Sample Name
Sample Code
 +8.63%
4
United Microelectronics
UMC
+5.32%
5
Chagee Holdings
CHA
+3.37%
View More
Middle East conflict spreads to the stock market! How should investors respond?
Signs of restarting the second round of US-Iran talks have emerged. According to reports, Iran's foreign minister arrived in Pakistan on Fri Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -